|
Paul Mlakar, Jr.,
President
 Paul Mlakar, Jr. joined
BiologicsMD as President in 2009. He has over 15 years of
government, corporate, and small business leadership experience. He
has spent the last 10 years leading start-ups and recently guided a
company from $10MM in revenue to $50MM in 5 years. From 1995 to
1998 he served in the United States Army with tours in the Middle
East and Central America commanding units in key humanitarian and
infrastructure campaigns. Mr. Mlakar earned his MBA from the Sam M.
Walton College of Business at the University of Arkansas and is a
graduate of the United State Military Academy, West
Point.
|
| |
|
Rob Gensure, M.D.,
Ph.D., Chief Medical Officer
Dr. Rob Gensure joined BiologicsMD as Chief Medical Officer in
2009. He is the inventor of the PTH-CBD medication and practices
pediatric endocrinology and pediatrics at the Albert Einstein
College of Medicine in New York. He is board certified in pediatric
endocrinology and pediatrics. Dr. Gensure graduated from Tulane
University School of Medicine and completed his residency at
Massachusetts General Hospital. |
| |
|
Dr. Jim Shook, Chief
Development and Regulatory Officer
 Dr. Jim Shook joined BiologicsMD as Chief
Development and Regulatory Officer in 2009. He has over 35 years of
experience in drug development and regulatory affairs. He has
successfully guided over 25 drugs through the FDA approval process
including 12 drugs with complete development and regulatory
responsibility. Dr. Shook is a former executive with Abbot,
Genentech, Vice President Research and Development at Fujisawa and
Executive Vice President at Salix, Athersys and Quark
Pharmaceuticals. He received his Ph.D. in 1969, MS and BS degrees
in 1963 and 1965, respectively.
|
| |
|
Dr. Robyn Goforth,
Chief Scientific Officer
 Dr. Robyn Goforth joined BiologicsMD
as Chief Scientific Officer in 2009. She has over 13 years
experience in functional protein design and protein production. She
has published over a dozen scientific papers in the fields of
biochemistry and bioengineering. Dr. Goforth has also been
principal investigator and co-principal investigator on over $10MM
in National Institute of Health, Department of Energy, and Small
Business Innovation Research grants. She was named in June 2011 one
of the top 40 business leaders under 40 by the Arkansas Business
Journal.
|
| |
|
Dr. Misty Stevens,
Chief Operating Officer
 Dr. Misty Stevens joined BiologicsMD
as Chief Operating Officer in 2009. She has over 6 years of
experience in biologics development with a technology start-up
company as operations director overseeing outsourced manufacturing
and toxicology studies. She has co-authored two pre-IND packages
for FDA submission and has been co-principal investigator for over
$10MM in National Institutes of Health grants. Dr. Stevens earned a
Ph.D. in Biological Sciences from the University of Arkansas,
completed a postdoctoral fellowship at Harvard Medical School, and
received a MBA from the Sam M. Walton College of Business at the
University of Arkansas.
|
| |
